| Literature DB >> 34941118 |
Peiming Sang1, Yanyan Ma2, Binhui Chen1, Ming Zhang1.
Abstract
ABSTRACT: This study aimed to describe change trends in serum creatine kinase (CK) values for patients undergoing anterior cervical spinal surgery and identify risk factors that affect the CK values perioperatively, intending to decrease the degree of the iatrogenic invasiveness of the procedure.We retrospectively analyzed 122 patients undergoing anterior cervical spinal surgery from January 2019 to May 2020. For all patients, CK level was measured 1 day before the operation. Daily CK levels were evaluated on postoperative days 1 to 7. These data were analyzed in terms of age, gender, the use of microendoscopy during surgery, the number of cervical operative segments, and operative methods to determine whether these risk factors influenced postoperative CK increases.A total of 122 patients were enrolled. The preoperative average CK level was 72.7 U/L, and the average CK levels were 130.6, 122.4, 99.1, 82.8, 73.7, 63.9, and 55.4 U/L from the postoperative day (POD) 1 to POD7, respectively. CK level changes on POD1 increased with the number of operated cervical segments. However, changes were not related to age, gender, microendoscopy, or the operative method.Increased serum CK level was associated with the number of cervical operative segments, rather than age, gender, the use of microendoscopy, or the operative methods. These findings suggest that the number of cervical operative segments determined the degree of iatrogenic injury for anterior cervical spinal surgery.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34941118 PMCID: PMC8702170 DOI: 10.1097/MD.0000000000028300
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Variables and average CK levels.
| Variable | Number of patients | Mean ± standard deviation | Median | Min | Max |
| Preoperative CK (U/L) | 112 | 72.7 ± 26 | 79 | 18 | 130 |
| POD1 CK(U/L) | 112 | 130.6 ± 48.1 | 124 | 57 | 286 |
| POD2 CK(U/L) | 112 | 122.4 ± 68.7 | 106.5 | 51 | 360 |
| POD3 CK(U/L) | 112 | 99.1 ± 54.5 | 83.5 | 40 | 274 |
| POD4 CK(U/L) | 112 | 82.8 ± 53.9 | 63 | 29 | 343 |
| POD5 CK(U/L) | 112 | 73.7 ± 48.5 | 55 | 30 | 292 |
| POD6 CK(U/L) | 112 | 63.9 ± 39.8 | 50 | 26 | 200 |
| POD7 CK(U/L) | 112 | 55.4 ± 34.1 | 45 | 20 | 186 |
| CK change at POD1 (U/L) | 112 | 57.9 ± 44.4 | 49.5 | −40 | 191 |
CK = creatine kinase, POD = postoperative day.
Correlation of CK level with the age.
| Age | Variable | Mean ± standard deviation | Median | Min | Max | Pearson correlation (r-value) | |
| 58.96 ± 10.08 | Preoperative CK | 72.7 ± 26 | 79 | 18 | 130 | −0.125 | .1907 |
| 58.96 ± 10.08 | CK value at POD1 | 130.6 ± 48.1 | 124 | 57 | 286 | −0.012 | .8995 |
| 58.96 ± 10.08 | CK change at POD1 | 57.9 ± 44.4 | 49.5 | −40 | 191 | 0.06 | .5306 |
CK = creatine kinase, POD = postoperative day.
CK value as a function of patient gender.
| Variable | Gender | Number of patients | Mean ± standard deviation | Median | Min | Max | Statistic value | |
| Preoperative CK | Male | 64 | 80.1 ± 24.9 | 87.5 | 29 | 130 | 3.668 | 3.787 × 10–4 |
| Female | 48 | 62.9 ± 24.3 | 65.5 | 18 | 100 | |||
| CK value at POD1 | Male | 64 | 144.97 ± 50.9 | 138.5 | 69 | 286 | 3.86 | 1.911 × 10–4 |
| Female | 48 | 111.5 ± 36.5 | 102 | 57 | 213 | |||
| CK change at POD1 | Male | 64 | 64.8 ± 45.4 | 51.5 | 10 | 191 | 1.929 | .0563 |
| Female | 48 | 48.7 ± 41.8 | 49 | −40 | 171 |
CK = creatine kinase, POD = postoperative day.
Comparison of the CK levels for surgery with microendoscopy or not.
| Variable | Surgery method | Number of patients | Mean ± standard deviation | Median | Min | Max | Statistic | |
| Preoperative CK | With microendoscopy | 22 | 68.68 ± 23.49 | 73 | 36 | 120 | 0.812 | .419 |
| Without microendoscopy | 90 | 73.7 ± 26.6 | 80 | 18 | 130 | |||
| CK value at POD1 | With microendoscopy | 22 | 134.8 ± 60.09 | 118 | 73 | 286 | −0.453 | .652 |
| Without microendoscopy | 90 | 129.6 ± 45 | 124 | 57 | 242 | |||
| CK change at POD1 | With microendoscopy | 22 | 66.1 ± 4.94 | 56 | −10 | 191 | −0.968 | .335 |
| Without microendoscopy | 90 | 55.9 ± 4.32 | 49 | −40 | 171 |
CK = creatine kinase, POD = postoperative day.
The CK levels of these groups.
| Variable | Group | Number of patients | Mean ± standard deviation | Median | Min | Max |
| Preoperative CK | 1ACDF | 35 | 69.2 ± 22.17 | 69 | 32 | 112 |
| 2ACDF | 26 | 83.3 ± 21.29 | 88 | 36 | 114 | |
| 3ACDF | 8 | 64.38 ± 33.78 | 58.5 | 33 | 120 | |
| 1ACCF | 23 | 72.26 ± 23.67 | 74 | 29 | 100 | |
| 1ACCF with 1ACDF | 20 | 69.1 ± 34.4 | 74 | 18 | 130 | |
| CK value at POD1 | 1ACDF | 35 | 105.9 ± 36.27 | 98 | 57 | 213 |
| 2ACDF | 26 | 145.3 ± 32.27 | 141 | 92 | 214 | |
| 3ACDF | 8 | 172.5 ± 80.8 | 159.5 | 85 | 286 | |
| 1ACCF | 23 | 127.1 ± 34.2 | 124 | 75 | 183 | |
| 1ACCF with 1ACDF | 20 | 142.2 ± 60.96 | 131.5 | 71 | 242 | |
| CK change at POD1 | 1ACDF | 35 | 36.7 ± 42.95 | 28 | −40 | 171 |
| 2ACDF | 26 | 62 ± 24.89 | 57 | 32 | 114 | |
| 3ACDF | 8 | 108.13 ± 50.44 | 103 | 48 | 191 | |
| 1ACCF | 23 | 54.8 ± 42.44 | 42 | 13 | 154 | |
| 1ACCF with 1ACDF | 20 | 73.15 ± 47.1 | 66 | 9 | 139 |
ACCF = anterior cervical corpectomy fusion, ACDF = anterior cervical discectomy fusion, CK = creatine kinase, POD = postoperative day.
Comparison of CK level among different segment of ACDF.
| Variable | Group | Number of patients | Mean ± standard deviation | Median | Min | Max | ||
| Preoperative CK | 1ACDF | 35 | 69.2 ± 22.17 | 69 | 32 | 112 | 1.58 | .185 |
| 2ACDF | 26 | 83.3 ± 21.29 | 88 | 36 | 114 | |||
| 3ACDF | 8 | 64.38 ± 33.78 | 58.5 | 33 | 120 | |||
| CK value at POD1 | 1ACDF | 35 | 105.9 ± 36.27 | 98 | 57 | 213 | 5.526 | 4.399 × 10–4 |
| 2ACDF | 26 | 145.3 ± 32.27 | 141 | 92 | 214 | |||
| 3ACDF | 8 | 172.5 ± 80.8 | 159.5 | 85 | 286 | |||
| CK change at POD1 | 1ACDF | 35 | 36.7 ± 42.95 | 28 | −40 | 171 | 6.194 | 1.601 × 10–4 |
| 2ACDF | 26 | 62 ± 24.89 | 57 | 32 | 114 | |||
| 3ACDF | 8 | 108.13 ± 50.44 | 103 | 48 | 191 |
ACDF = anterior cervical discectomy fusion, CK = creatine kinase, POD = postoperative day.
Comparison of CK levels between 2ACDF group and 1ACCF group.
| Variable | Group | Number of patients | Mean ± standard deviation | Median | Min | Max | ||
| Preoperative CK | 2ACDF | 26 | 83.3 ± 21.29 | 88 | 36 | 114 | −1.72 | .092 |
| 1ACCF | 23 | 72.26 ± 23.67 | 74 | 29 | 100 | |||
| CK value at POD1 | 2ACDF | 26 | 145.3 ± 32.27 | 141 | 92 | 214 | −1.918 | .061 |
| 1ACCF | 23 | 127.1 ± 34.2 | 124 | 75 | 183 | |||
| CK change at POD1 | 2ACDF | 26 | 62 ± 24.89 | 57 | 32 | 114 | −0.732 | .468 |
| 1ACCF | 23 | 54.8 ± 42.44 | 42 | 13 | 154 |
ACCF = anterior cervical corpectomy fusion, ACDF = anterior cervical discectomy fusion, CK = creatine kinase, POD = postoperative day.
Comparison of CK levels between 3ACDF group and 1ACCF with 1ACDF group.
| Variable | Group | Number of patients | Mean ± standard deviation | Median | Min | Max | ||
| Preoperative CK | 3ACDF | 8 | 64.38 ± 33.78 | 58.5 | 33 | 120 | 0.326 | .747 |
| 1ACCF with 1ACDF | 20 | 69.05 ± 34.44 | 74 | 18 | 130 | |||
| CK value at POD1 | 3ACDF | 8 | 172.5 ± 80.8 | 159.5 | 85 | 286 | −1.083 | .289 |
| 1ACCF with 1ACDF | 20 | 142.2 ± 60.96 | 131.5 | 71 | 242 | |||
| CK change at POD1 | 3ACDF | 8 | 108.13 ± 50.44 | 103 | 48 | 191 | −1.742 | .093 |
| 1ACCF with 1ACDF | 20 | 73.15 ± 47.06 | 66 | 9 | 139 |
ACCF = anterior cervical corpectomy fusion, ACDF = anterior cervical discectomy fusion, CK = creatine kinase, POD = postoperative day.